Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Discovers Large Near Surface EM Conductor SE of Cam Copper Mine (click to learn more) Xcyte Digital Corp. Releases "Xperience" Subscription Service (click to learn more) Star Diamond: High Modelled Diamond Prices and High Proportions of Type IIa Diamonds (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Jasper Therapeutics Inc JSPR

Healthcare Biotechnology
Jasper Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing therapeutics targeting mast cell driven diseases, such as Chronic Spontaneous Urticaria (CSU) and Chronic Inducible Urticaria (CIndU). It also has ongoing programs in diseases where targeting diseased hemopoietic stem cells can provide benefits, such as Lower to Intermediate Risk... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:JSPR)

Jasper Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Developments

GlobeNewswire 2 days ago

Jasper Therapeutics Announces Briquilimab Development Program in Asthma

GlobeNewswire 3 days ago

Jasper Therapeutics to Present at Upcoming Investor Conferences in May

GlobeNewswire 9 days ago

Jasper Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire April 2, 2024

Jasper Therapeutics to Participate in the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference

GlobeNewswire March 21, 2024

Jasper Therapeutics Announces First Patient Dosed in Phase 1b/2a SPOTLIGHT Clinical Study of Briquilimab in Chronic Inducible Urticaria

GlobeNewswire March 19, 2024

New Positive Data Presented on Briquilimab Conditioning in Patients with Fanconi Anemia

GlobeNewswire March 15, 2024

Jasper Therapeutics Reports Fiscal 2023 Financial Results and Recent Corporate Developments

GlobeNewswire March 4, 2024

Jasper Therapeutics to Present at the 43rd Annual TD Cowen Healthcare Conference

GlobeNewswire February 26, 2024
View More News ››

Opinion & Analysis (NDAQ:JSPR)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:JSPR)

Jasper Therapeutics to Present at the Oppenheimer 34th Annua

JUST IN: $JSPR Jasper Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Conference | BenzingaREDWOOD CITY, Calif., Feb...
whytestocks - February 7, 2024

Jasper Therapeutics to Present at the Oppenheimer 34th Annua

Just In: $JSPR Jasper Therapeutics to Present at the Oppenheimer 34th Annual Healthcare ConferenceREDWOOD CITY, Calif., Feb. 07, 2024...
whytestocks - February 7, 2024

Jasper Therapeutics Announces Pricing of $50 Million Underwr

News; $JSPR Jasper Therapeutics Announces Pricing of $50 Million Underwritten Offering of Common StockREDWOOD CITY, Calif., Feb. 06...
whytestocks - February 6, 2024

When (JSPR) Moves Investors should Listen

Breaking News: $JSPR When (JSPR) Moves Investors should Listen2024-02-05 01:50:00 ET Stock Traders Daily has produced this trading...
whytestocks - February 5, 2024

JSPR ..... I see dead people !!!!

Not me ; )
Iseneschal - January 3, 2023

JSPR..... Hmmmmm

EDGAR Entity Landing Page (sec.gov)
Iseneschal - January 3, 2023
View more Bullboard ››

Noble Mineral Exploration Inc.

Noble Mineral Exploration Inc.

Noble Mineral Exploration Inc. is a Canada-based junior exploration company. The Company is engaged in the exploration and ...
View More »